Related Experiment Video
Updated: Jul 10, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Pediatric acute liver failure in a child with arsenic toxicity and underlying rotor syndrome
Shivangi Tetarbe1, Dhruv Gandhi1, Lakshmi Shobhavat2
1Department of Pediatric Gastroenterology and Hepatology, Bai Jerbai Wadia Hospital for Children, Acharya Dhonde Marg, Parel, Mumbai, MH 400012, India.
Insights
Unregulated herbal medicines can cause pediatric acute liver failure (PALF). A 7-year-old boy died from arsenic toxicity after consuming herbal medicine, highlighting the dangers of contaminated products.
Area of Science:
- Pediatric Hepatology
- Toxicology
- Genetics
Background:
- Pediatric acute liver failure (PALF) has diverse causes, including infections, metabolic disorders, and toxins.
- Herbal medicines are an underrecognized etiological factor in PALF.
Abstract:
Pediatric acute liver failure can result from infections, metabolic disorders, autoimmune diseases, toxins, or malignancies. It is crucial to consider herbal medicines as an etiological factor in such cases. We report a 7-year-old boy presenting with PALF from arsenic toxicity after consuming herbal medicine. He presented with jaundice, fever, vomiting, and lethargy, with hepatomegaly and signs of raised intracranial tension on examination. He had taken herbal medicine for the jaundice. His toxicology screen revealed high levels of arsenic and lead in serum and urine. Whole exome sequencing incidentally identified pathogenic mutations of the SLCO1B1 and SLCO1B3 genes, suggestive of Rotor syndrome (RS). Despite intensive care, including continuous renal replacement therapy and plasmapheresis, he died from multiorgan dysfunction and sepsis. This case shows the risks of unregulated herbal formulations containing toxins and explores the potential interaction between RS and arsenic toxicity.
Related Concept Videos
Hepatic Encephalopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Toxicity: Risk factors

